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An important aspect of functional magnetic resonance imaging (fMRI) is the study of brain hemodynamics, and MR arterial spin
labeling (ASL) perfusion imaging has gained wide acceptance as a robust and noninvasive technique. However, the cerebral blood
ﬂow (CBF) measurements obtained with ASL fMRI have not been fully validated, particularly during global CBF modulations.
We present a comparison of cerebral blood ﬂow changes (ΔCBF) measured using a ﬂow-sensitive alternating inversion recovery
(FAIR) ASL perfusion method to those obtained using H2
15O PET, which is the current gold standard for in vivo imaging of CBF.
To study regional and global CBF changes, a group of 10 healthy volunteers were imaged under identical experimental conditions
during presentation of 5 levels of visual stimulation and one level of hypercapnia. The CBF changes were compared using 3 types
of region-of-interest (ROI) masks. FAIR measurements of CBF changes were found to be slightly lower than those measured with
PET (average ΔCBF of 21.5 ± 8.2% for FAIR versus 28.2 ± 12.8% for PET at maximum stimulation intensity). Nonetheless, there
was a strong correlation between measurements of the two modalities. Finally, a t-test comparison of the slopes of the linear ﬁts of
PET versus ASL ΔCBF for all 3 ROI types indicated no signiﬁcant diﬀerence from unity (P>. 05).
Copyright © 2008 Jean J. Chen et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
Neuronal activity results in focal changes in hemodynamics,
metabolism, and blood oxygenation of associated brain
areas. Functional maps of cerebral blood ﬂow (CBF) can be
used to monitor hemodynamic changes in the healthy brain
as well as alterations associated with cerebrovascular disease.
Positron emission tomography (PET) is capable of providing
in vivo quantitative measures of CBF and has evolved to be
considered the gold standard for studying cerebral hemo-
dynamics. However, PET imaging involves the injection
of radioactive tracers, which limits its repeatability and
application in healthy volunteers. Among other limitations
are low temporal and spatial resolution, low signal-to-noise
ratio (SNR), as well as the requirement for a cyclotron. Thus,
magnetic resonance (MR) perfusion imaging, being widely
available and having relatively high spatial and temporal
resolution, is increasingly seen as an attractive alternative to
PET.
MR perfusion imaging is performed using dynamic
susceptibility contrast (DSC) techniques or arterial spin
labeling (ASL) [1, 2]. DSC imaging has not been widely
applied in human functional research due to the require-
ment of an exogenous contrast agent and limited temporal
resolution. ASL is based on the detection of magnetically
labeledarterialbloodwaterspinsandhasthereforebeenused
with more success in functional MRI (fMRI) studies. Pulsed
ASL methods such as proximal inversion with control for
oﬀ-resonance eﬀects (PICORE), ﬂow-sensitive alternating
inversion recovery (FAIR), quantitative imaging of perfusion
usingasinglesubtraction(QUIPSSI/II),andQUIPSSIIwith
thin-slice TI1 and periodic saturation (Q2TIPS) have greatly
facilitated perfusion-based fMRI [2–8].
The validation of MR perfusion measurements using
variousinvasiveandnoninvasivemethodshasbeenatopicof
considerable interest. Walsh et al. compared CBF measured
using continuous ASL and radioactive microspheres using
a rat model and found ASL to underestimate CBF under
high ﬂow [9]. On the other hand, based on radiotracer-
enhanced quantitative autoradiography ﬂow measurements
in rats, Ewing et al. concluded that CBF were overestimated
by ASL under ischemia [10]. In healthy humans, Østergaard
etal.[11]foundahighlylinearrelationshipbetweenPETand
DSC MR CBF measurements (using Gd-DTPA), consistent2 International Journal of Biomedical Imaging
with the values reported in the literature. Similar ﬁndings
were reported by Carroll et al. [12], Lin et al. [13], and
Grandin et al. [14] in healthy human subjects. Quantitative
CBF values of 68.1 ± 9.5a n d2 6 .7 ± 5.0mL/100g/min were
measured for grey matter (GM) and white matter (WM),
respectively [13]. In addition, Grandin et al. reported a high
correlationbetweenDSCandPETCBFmeasurementsunder
the eﬀect of vasodilative pharmacological agents, with PET
results having higher reproducibility [14]. However, Carroll
and Grandin found that GM CBF values were overestimated
with DSC MR possibly due to sensitivity to the presence of
large blood vessels [12, 14].
Ye et al. reported a comparison of resting CBF using
steady-state ASL and PET and measured GM CBF of
64.12 and 67.13mL/100 g/min, respectively. The PET and
ASL measurements were not statistically diﬀerent from one
another and were both in good agreement with literature
values [15]. However, the WM ASL CBF (23.8mL/100
g/min) was 30% lower compared to PET (33.7mL/100
g/min), the discrepancy being attributed to the arterial
tagging time diﬀerence between GM and WM, speciﬁc to
the quantitative model employed in this study. In epilepsy
patients, Liu et al. studied perfusion in the temporal lobe
usingtheFAIR-preparedhalf-Fouriersingle-shotturbospin-
echo (HASTE) technique [16] and also found a statisti-
cally signiﬁcant correlation between ASL and PET data. A
functional comparison involving PET and ASL was ﬁrst
performed by Zaini et al. using a simple ﬁnger-tapping task
[17]. However, the matching of spatial resolution and noise
was not possible for PET and ASL data. In a more recent
s t u d yb yF e n ge ta l .[ 18], another comparison of PET and
FAIR fMRI measurements of CBF changes was reported,
using a single level of visual stimulation in healthy subjects.
Once again, results obtained by the two methods were very
similar, with the PET CBF percent change being slightly
higher than that of FAIR (ΔCBF of 38.79% versus 36.95%).
Notwithstanding the contributions of the above studies,
severalfactorslimitthescopeandapplicabilityoftheexisting
studies. Firstly, an accurate comparison of PET and fMRI
perfusion is challenging due to methodological diﬀerences.
In particular, spatial resolution disparities lead to diﬃculties
in accurate region-of-interest (ROI) registration and partial-
volume matching, which are critical for direct comparisons.
Secondly, both techniques are inherently sensitive to physio-
logical variations, which reduce measurement reproducibil-
ity. Carroll et al. measured interexam ASL CBF variation in
a single subject to be as high as 20mL/100g/min in GM
and 15mL/100g/min in WM, while those observed with
P E Tw e r e4 - 5 m L / 1 0 0 g / m i n[ 12]. Grandin et al. observed
variations of up to 13% for PET and 16% for MR CBF
measurements at rest in the same individual [14]. As a result,
high intersubject and interexam variability between PET and
MR are expected, particularly in inexperienced volunteers
scanned over several days. Thirdly, past comparisons of CBF
measurements were largely performed without functional
stimulation, and for those within the fMRI context, the
impact of graded stimulus intensity [8]h a sn o tb e e n
explored. Finally, previous ASL and PET CBF data were not
always collected in similar environments.
We were interested in evaluating the relative accuracy of
the FAIR ASL method for ΔCBF measurements in compari-
son with PET. Previous ASL research [19, 20] has shown the
accuracyofFAIRindeterminingCBFtobedependentonthe
transit delay and label width, which can be variable across
subjects and experimental conditions. This has led to the
introduction of techniques less sensitive to transit delay and
bolus width, such as QUIPSS II [4], and their adoption by
our group [21–23] and others. However, the FAIR technique
[24] has been and continues to be used extensively in the
literature as a well-established method for the investigation
of functional hemodynamics [3, 6–8]. Notably, some widely
adopted and investigated biophysical models of the BOLD
signal have been developed and validated based on CBF data
using FAIR [3, 18, 25–27]. Thus, a dedicated assessment of
the validity of FAIR for CBF measurement would be a highly
valuable addition to our knowledge.
In this study, we compare FAIR fMRI measurements of
CBF with those made using PET during graded levels of
visual stimulation. In addition, we measured CBF changes
induced by hypercapnia, which has been employed to
explore global, activation-independent perfusion increases
and applied to cross-subject calibrations of the BOLD
response [25]. Also, over the course of our experiments, the
conditions for ASL and PET data collection were also closely
matched and monitored.
2. METHODS AND MATERIALS
2.1. Experimentaldesign
Visual stimuli were generated using locally developed soft-
ware (GLStim) based on the OpenGL graphics library
(Silicon Graphics, Mountain View, Calif, USA). The baseline
condition consisted of a uniform grey ﬁeld, while the
activation pattern was a yellow-blue radial checkerboard
with 30 spokes and 6.5 rings of equal radial thickness,
reversing contrast at 4Hz. The checkerboard contains both
color and luminance contrast designed to produce robust
local CBF increase in the primary visual cortex (V1) [3, 8].
In an eﬀorttomaintainthesubjects’attention,aﬁxationtask
(a small arrow randomly changing directions) was present at
the centre of the ﬁeld of view (FOV) throughout the scans.
Subjects were requested to continuously report the arrow
direction by means of an MR-compatible mouse.
The graded visual stimulation and hypercapnia schemes
were matched to those previously employed in calibrated
fMRIstudiesofﬂow-metabolismcoupling[3].Inadditionto
the uniform grey-ﬁeld reference condition, the subjects were
presented with 4 graded levels of visual stimulation, ranging
from 25% to 100% intensity, while inhaling atmospheric
composition medical air supplied at 16L/min. Furthermore,
mild hypercapnia (induced using air mixture of 5:21:74%
CO2:O2:N2) was used to study global CBF changes. Both
PET and ASL scans included 6 sessions of 3 minutes, each
consisting of one visual-respiratory condition played out
continuously. Each stimulation session was preceded and
followed by a baseline condition (Figures 1 and 2)o f1a n d2
minutes, respectively.Jean J. Chen et al. 3
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Figure 1: (a) The fMRI experimental protocol consisted of 6 randomly presented sessions (baseline, hypercapnia, and 4 levels of visual
stimulation). (b) The interleaved BOLD-FAIR sequence was repeated 30 times during each run of 6 minutes, composed of a 1-minute
baseline, 3-minute stimulation, and 2-minute baseline period. Scans shaded in grey (1 minute post onset and cessation of stimulation plus
ﬁrst scan in the run) were excluded in percent change calculations to ensure that time-averaged data included only physiological changes in
steady state. (c) The basic structure of the BOLD-FAIR sequence consists of 2 BOLD acquisitions (averaged to form 1 BOLD-contrast image)
interleaved with 1 slice selective and 1 nonselective ASL acquisition. (d) These 4 acquisitions produce a ﬂow-weighted FAIR image through
subtraction and a BOLD image through addition.
Atotalof10healthyhumansubjects(8males,2females),
aged 23.9 ± 3.3 years, were imaged under the above six
experimental conditions. Informed consent was obtained
from every subject prior to each PET and MRI scanning
session, with the experimental protocol being approved by
the Research Ethics Board of the Montreal Neurological
Institute (MNI, Montreal, Canada). In order to achieve
maximal similarity between the PET and fMRI experimental
conditions, the sizes of the projected checkerboards were
matched, as well as the lighting intensity at the two imaging
locations. During the scans, subjects were asked to breathe
through a nonrebreathing face mask, allowing control of the
incoming air composition.
2.2. Magneticresonanceimaging
Subjects were immobilized with a foam headrest and head
restraints. A nasal cannula connected to a capnometer was
used to monitor end-tidal carbon dioxide (ETCO2)a n d
the respiratory rate, whereas the arterial oxygen saturation
(O2Sat) and the pulse rate were measured with a ﬁnger
pulse oximeter. The pulse and respiratory rates are indicators
of blood CO2 tension. The stimulus was presented by an
adjustable back-projection mirror mounted on the head coil.
The MR scans were performed on a 1.5T Siemens
Magnetom Vision system (Siemens, Erlangen, Germany). To
optimize the SNR of the functional data in the visual cortex,
a transmit-receive surface coil placed near the occipital
lobe was used to acquire all functional images. Thus, prior
to the functional scans, a surface-coil T1-weighted (T1W)
anatomical scan, acquired at a resolution of 1 × 1 × 2mm 3,
was used in slice selection and alignment of all functional
data. However, as the surface-coil anatomical data has highly
nonuniform intensity, registration to PET data using our
local software was diﬃcult. Therefore, an additional high-
resolution 1 × 1 × 1mm 3 T 1 Wa n a t o m i c a ls c a nw i t hah e a d4 International Journal of Biomedical Imaging
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Figure 2: (a) The PET experimental protocol consisted of 6 randomly presented sessions (baseline, hypercapnia, and 4 levels of visual
stimulation). A tracer bolus injection was given at the start of each block. (b) Each run has a 3-minute acquisition period divided in 12
5-second, 6 10-second, and 3 20-second frames, followed by 15 minutes of rest. (c) A volume of activity distribution was acquired during
each frame. (d) This series of distribution images and the blood activity curve were ﬁt into a kinetic model, resulting in a CBF map.
coil was also acquired to facilitate the registration of PET and
surface-coil MR data. We use the interleaved FAIR-BOLD
echo-planarimagingsequenceasimplementedbyHogeetal.
[3] in order to directly evaluate their measurements as well
as to achieve simultaneous BOLD monitoring. Furthermore,
we selected imaging parameters to best enable replication of
experimental conditions in previous fMRI ﬂow-metabolism
studies [3, 28]. The FAIR inversion time and echo time
(TE)were900millisecondsand20milliseconds,respectively,
whiletheBOLDTEwas50milliseconds.A7-mmthicksingle
obliquesliceparalleltothecalcarinesulcuswasacquiredona
64×64 matrix with a 5×5mm 2 inplane voxel size. As seen in
Figure 1, the repetition time of the sequence was 12 seconds,
allowing acquisition of a total of 60 frames per 6 minutes
run, 30 FAIR and 30 BOLD frames. Of these 30 frames,
11 were excluded (1 minute postonset and postcessation of
stimulation plus the ﬁrst scan in the run) to ensure that
only data corresponding to the physiological steady-state
response was examined. The chosen FAIR implementation
minimizes errors related to the tagging slab arrival time
and width through the use of a single-slice acquisition and
a body coil inversion [8] .I no r d e rt oo b t a i na na c c u r a t e
maskinglocationofV1(primaryvisualcortex),BOLD-based
retinotopic mapping was performed in a separate session,
using a visual stimulus composed of a thick black-and-white
expanding ring, also designed using GLStim [3, 28]. A total
of 16 slices of 4mm parallel to the calcarine sulcus were
acquiredusing a BOLDsequenceduring 6 randomly ordered
runs of a 6-minute visual stimulation.
2.3. Positronemissiontomography
The protocol for the PET experiments was adapted from
previous PET studies aimed at reproducing MRI results
[29]. The subjects were immobilized using a self-inﬂating
foam headrest, which minimized motion during scans.
The stimulus was presented through an adjustable mirror
mounted on the patient table. As previously described, theJean J. Chen et al. 5
O2Sat level and pulse rate were monitored using a ﬁnger
pulse-oxymeter, while a capnometer connected via a nasal
cannula monitored the ETCO2 and the respiratory rate.
In addition, a short indwelling catheter was placed by an
anesthetist into the left radial artery for blood sampling and
a more precise examination of blood gases. A three-way stop
cock allowed for simultaneous automatic (using a locally
developed sampling system for blood activity measurement)
and manual (for blood gases examination) blood sample
withdrawal. Automatic blood sampling was performed at
0.5-second intervals throughout the data collection period.
A ﬁne needle catheter was placed into the antecubital vein of
the right arm for injection of the isotope.
P E Ti m a g e sw e r ea c q u i r e do na nE C A TE X A C TH R +
(CTI/Siemens, Knoxville, TN) whole-body tomography
system operating in three-dimensional (3D) mode. The
volumetric images were reconstructed on 128×128 matrices
of 2 × 2mm 2 pixels using ﬁltered back-projection with an
8-mm Hanning ﬁlter. For each of the 6 sessions, 10mCi of
H2
15O were injected. The H2
15O isotopes were prepared in
a Cyclone 18/9 cyclotron (IBA, Louvain-la-Neuve, Belgium)
adjacent to the scanner. The reconstructed images were
automatically corrected for random and scattered events,
detector eﬃciency variation and dead time [30, 31]. Also,
a transmission scan was collected for each subject before
the experiments for estimating attenuation of the 511keV
gamma rays as a function of tissue density [32]. A nor-
malization scan was acquired for eliminating eﬀects due to
ring geometry and crystal sensitivity [33]. The stimulation
conditions were presented in random order. As shown in
Figure 2, during each 3-minute scan, the subjects were
presented with only one type of stimulation, which started
1 minute before the start of the scan. This delay was designed
to enable condition matching with fMRI. Arterial blood
sampling and dynamic imaging started at injection time,
and each scan was followed by a 15-minute resting period,
allowing the radioisotope to decay before a new injection.
Duetotheshorthalf-lifeofH2
15O(2minutes)anditskinetic
behaviour, the observed H2
15O activity changes are very
fast immediately after injection, requiring the acquisition of
more frames at the beginning of the scan. Thus, each 3-
minute scan consists of 21 frames acquired in 12 5-second
intervals, followed by 6 frames at 10-second and 3 frames at
20-second intervals. Finally, due to the tracer kinetic model
ﬁttingrequiredforPETdata,onlyonevolumetricCBFimage
was obtained for each experimental condition and no time
evolution was measured.
2.4. Dataanalysis
Flow-sensitive MR perfusion images were obtained by
subtraction of the slice-selective and nonselective FAIR
acquisitions. Subject motion, assessed by examining the
temporal standard deviation images, was deemed negligible.
Quantitative analysis of PET images was performed using
the two-compartment weighted integration method [34].
No motion correction was performed given the longer
acquisition time, due to which the eﬀects of motion are
greatlyreduced.ThreediﬀerentmethodsofselectingtheROI
were examined. The ROIs were deﬁned on an individual
basis due to intersubject slice placement variability. In
addition, for group analysis, PET (volume) and fMRI data
(single-slice) were resampled into the same reference frame,
accounting for PET’s lower image resolution.
(i) V1-based ROI: The ﬁrst ROI selection criterion
involved choosing only voxels within the primary visual
cortex (V1), since this region should contain the most
reliable activation for the stimulus used. V1 was deﬁned
using fMRI-based retinotopic mapping with an eccentricity
range of 5–10◦, as described previously [3, 8, 35], and
resampled onto the slice corresponding to the fMRI data
for each subject. However, retinotopic V1 regions meeting
these criteria can be small, rendering the masking process
highly sensitive to misregistration between MRI and PET.
Also, a small ROI mask might produce variable results, with
activation data outside V1 ignored. Hence, other ROIs types
were considered in the analysis.
(ii) t-map-based ROI: The second type of ROI was
obtained based on activation t-maps for both PET and
fMRI CBF images. For fMRI, individual t-maps were calcu-
lated using fMRIstat [36]. PET t-maps were automatically
generated with the locally developed software used for
PET analysis, DOT (version 1.8.0, S Milot, MNI) [37].
Both fMRI and PET t-maps were thresholded at the 0.05
signiﬁcance level to obtain the mask, accounting for multiple
comparisonsforeachsubject.TheoverlapbetweenfMRIand
PET masks was taken to be the ROI.
(iii) GM-based ROI: Since the CBF changes occur mostly
in GM, a third set of ROIs, consisting of a GM map in the
fMRI occipital lobe slice, was deﬁned for each subject. The
GM ROIs were obtained using Bayesian fuzzy classiﬁcation
[38] on the high resolution anatomical MR images. This is
well suited for hypercapnia studies, which are best analyzed
via the global demarcation of GM. The occipital GM ROIs
include activated visual cortical areas.
In this study, the raw FAIR fMRI images have a higher
spatial resolution than PET images. To maximize the degree
of matching between the MR and PET data, the surface-
coil MR anatomical scans were ﬁrst manually registered
to the head-coil images using Register (D MacDonald,
MNI) [39], then transformed into Talairach space. Prior
to the subsequent resampling the surface-coil fMRI data
into the head-coil and stereotaxic coordinates, the images
were blurred using a 12 × 12mm2 FWHM (full-width-at-
half-maximum) Gaussian kernel, resulting in a resolution
approximately equal to that of PET data. The postblurring
MR data was then resampled into a 1 × 1mm 2 grid
using trilinear interpolation. Since FAIR data is single slice,
PET data was transformed into the FAIR slice space [17].
Individual PET scans were registered to the ﬁrst PET scan
for each subject using an in-house implementation of the
variance-of-ratios algorithm [40]. Following this, an average
PET scan was calculated for registration of PET onto the
MR anatomical space. DOT was then used to transform the
registered PET images into Talairach space. These images
were subsequently resampled onto the same slice from the
fMRI data in Talairach space, and the ﬁnal sampling of the
PET CBF slices corresponds to that of fMRI for each subject.6 International Journal of Biomedical Imaging
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Figure 3: Sample ROIs (shown in red) deﬁned for one subject. The V1 ROI was obtained by retinotopic mapping, the t-map ROI included
commonvoxelsfromthresholdedandresampledFAIRandPETt-maps,andthegreymatter(GM)ROIwasdeﬁnedbyBayesianclassiﬁcation
of the anatomical structures.
AllROImasks werealsoresampled into Tailarachspace, with
ar e s o l u t i o no f1×1 ×1mm 3.
To characterize the relationship between CBF changes
measured using PET and FAIR, a correlation analysis was
performed. The initial analysis was at the level of individual
CBF changes for each subject, averaged across all voxels
in the subject’s ROIs, while the subsequent analysis was
performed on the CBF data averaged across all subjects in
the individually deﬁned ROIs.
3. RESULTS
3.1. Physiologicalmonitoring
Overall,thepulseratewasnotinﬂuencedbytheaircomposi-
tion. It ranged from 55.6 to 58.3 beats/min (subject average)
throughout the experiment. The subjects also maintained a
reasonably constant respiratory rate, between 15.7 and 17.9
breaths/min. While ETCO2 was stable at 40.2–42.1mmHg
during the ﬁve normocapnia conditions, a small ETCO2
increase of about 4 to 6mmHg was observed during
hypercapnia, in agreement with rise in pressure introduced
by CO2. Finally, arterial saturation of O2 remained constant
at 98-99% throughout all the sessions.
3.2. Regionsofinterest
The three ROIs used for the ΔCBF comparisons were deﬁned
on a subject basis, as described in Methods and Materials,
and an example is shown in Figure 3. For all subjects, the V1
ROIs were the smallest, containing only between 0.101cc and
0.187cc, due to the stringent retinotopic mapping criteria.
V1 was correctly identiﬁed by the ROIs, but due to the small
mask size, the corresponding ΔCBF measurements are prone
to variations introduced by misregistration and motion. On
the other hand, the t-map ROIs contained between 0.202cc
and 0.407cc. To obtain the t-map ROI’s at P = .05, the
fMRI t-maps were thresholded at 5.42, and the PET maps at
4.45. A lower standard deviation was seen in the responses
detected in these ROIs, and the FAIR t-maps contained
no statistically signiﬁcant voxels for 2 of the 10 subjects.
The largest were the GM ROIs, covering 1.489-0.625 cc for
the same group of subjects. Some automatically classiﬁed
GM voxels were excluded by the certainty-level threshold,
but the ﬁnal GM ROIs were still signiﬁcantly larger than
the V1 ROIs. As previously mentioned, larger ROI masks
may include nonactivated voxels, leading to reduced levels
of measured ΔCBF. Nonetheless, the GM masks provide
an eﬀective means of comparing CBF measurement across
modalities, especially for the hypercapnia condition.
3.3. Activationtime-course
Time-series CBF data were obtained only from fMRI data
as PET measurements were not available as separate frames.
T h eB O L Da n dF A I Rt i m ec o u r s e sw e r eo b t a i n e db y
averaging all voxels in the ROI and shown in Figure 4 in
the V1 ROI of one subject (activation paradigm from left to
right: baseline, checkerboards from 25% to 100% intensity
and hypercapnia). We observed an increase in the level of
signal change with increasing checkerboard intensity for
both BOLD and FAIR. As expected, the activation SNR,
deﬁned as the ratio of the ROI mean over the standard
deviation during activation, was lower for FAIR than for
BOLD.
Intheaveragedtimecourses,FAIRΔCBFrangedbetween
11.4% and 22.5% for the various stimulation intensities, and
BOLD changes between 1.0% and 1.9%. These are in the
range of percent changes previously reported by Hoge et al.
using the same stimulation and acquisition design (between
1.1% and 2.2% for BOLD, and between 23% and 48% for
FAIR) [3, 28]. The measured percent changes in small ROIs
suchastheV1wereexpectedtodecreasewiththeapplication
of image blurring. This was true for average FAIR ΔCBF in
V1, where lower values (between 16.4% and 30.4%) were
measured compared to the study by Hoge et al. (where no
blurring was applied). Comparatively lower signal changesJean J. Chen et al. 7
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Figure 4: BOLD (a) and FAIR (b) time courses of the CBF percent
change in the V1 ROI averaged over 10 subjects are shown, from
left to right, corresponding to baseline, 25%, 50%, 75%, and 100%
intensity checkerboards and 5% hypercapnia. The horizontal bars
represent the 3-minute periods during which the stimulus was
on. An increase in signal change can be observed with increasing
checkerboard intensity for BOLD and FAIR perfusion, ranging
between 1.0%–1.9% and 11.4%–22.5%, respectively.
were also measured during hypercapnia (1.5% and 7.2% for
BOLD and FAIR, resp., compared to 2.5% and 21%, resp.,
in previous studies [3, 8]), despite similarity in observed
ETCO2 changes. However, our postblurring BOLD percent
c h a n g e si nt h eV 1R O I( b e t w e e n1 . 1 %a n d2 . 1 % )w e r es t i l l
similar to those obtained by Hoge et al.
3.4. FAIRversusPET
RelativePETCBFchangeswerecalculatedfromabsolutePET
CBF values and compared with relative FAIR ΔCBF changes.
PET ΔCBF values in the V1 ROIs for all 10 subjects, as well
as averaged ΔCBF over all subjects in the 3 ROI types, are
presentedinTable 1.Theresultsareintherangeofpublished
ΔCBF values [3]. However, the PET ΔCBF measurements
have a high standard deviation, largely attributable to the
abnormally high ΔCBF measured in subject 8. As previously
mentioned, ΔCBF time courses could not be obtained for
PETdata;instead,time-averagedΔCBFinthePETROIswere
compared to individual and group-averaged FAIR results.
The PET ΔCBF maps were found to have signiﬁcantly lower
SNR than FAIR (<1.0 for V1 and GM ROIs, and <2.27 for
t-map ROIs) for all the experimental conditions, as seen
in Table 1, and to demonstrate considerable intersubject
variability under each condition. We further noted that
ΔCBF for subject 10 in the V1 and GM ROIs were negative
for PET (possibly due to a relatively high PET CBF measured
at baseline) and only very slightly positive for fMRI (the
subject having no signiﬁcant voxels in the t-maps ROI). Data
fromthissubjectislikelytoaccountformuchofthestandard
deviation seen in both techniques.
The ΔCBF values measured with FAIR and PET in all
the ROIs during baseline and 4 graded levels of visual
stimulation are presented in Figure 5. PET data is shown
as having much higher standard deviation than FAIR mea-
surements, even when the GM ROIs were used. The group-
averaged results seem to provide a better indication of the
CBF changes. Table 2 summarizes the FAIR and PET ΔCBF
group averages. The FAIR baseline signal value was obtained
from the 6-minute baseline data, whereas in PET, since
only one baseline volume was obtained, the baseline percent
change was ﬁxed at 0%. The regions of activation-induced
ΔCBF in both the V1 and t-map ROIs were localized to
the expected site of activation. However, as seen in Figure 6,
the ΔCBF in the GM ROIs are lower, since many less than
maximally activated voxels are likely to have been included
in the mask. In addition, a postblurring data resolution of
14 × 14mm2 implies that both GM and WM contribution
can be expected in the same voxel; the GM signal intensity
thus diminished in both PET and FAIR [3]. We further
observed that for all ROIs, increases of FAIR ΔCBF appear
to correspond well with increases in visual stimulation
intensity, in agreement with previous observations [8]. This
was not the case for PET data. Finally, for the hypercapnic
condition, ΔCBF in all three ROIs were similar for FAIR and
PET.
3.5. Correlationanalysis
In Figure 6, group-averaged ΔCBF values for baseline and
the 4 visual stimulation conditions are shown as dots, while
the hypercapnic ΔCBF is represented by a triangle. The
hypercapnic ΔCBF values were quite consistent between
PET and MR measurements. Note that for all experimental
conditions, higher correlation was seen when comparing
the PET and MR group averages (Figure 6) than when
comparing the two sets of individual subject values (0.76,
0.87, 0.73 versus 0.45, 0.29, 0.57 for the V1, t-map and GM
ROIs, resp.). The line-ﬁtting algorithm used accounted for
data variance on both the PET and the ASL axis [3], and the
resulting slopes in all 3 ROI types were similar. χ2 values had
high probabilities (q = 92%–98%), well below the threshold
for rejection of the ﬁt (9.488 for 4 degrees of freedom at
P = .05). Furthermore, the two-tailed t-test was used to
assess whether the slopes were signiﬁcantly diﬀerent from
unity.Thet-valuesobtainedforall3ROIs(−0.10,−0.35,and
−0.06 for the V1, t-map, and GM ROIs, resp.) suggest that
the slopes of the MR-PET linear ﬁts do not diﬀer statistically
from unity.
4. DISCUSSION
Arterial spin labeling (ASL)-based perfusion fMRI tech-
niques are fast, noninvasive, have high resolution (temporal
andspatial),andarewidelyaccessible.Furthermore,ASLcan
easily be used in conjunction with other MR techniques to
provide information on a variety of physiological parameters
in a single session. The goal of this study was to compare8 International Journal of Biomedical Imaging
Table 1: CBF measured with PET in 10 subjects under 6 experimental conditions (baseline, 4 levels of graded visual checkerboard (CHB)
stimulation as well as hypercapnia (HC)) in the V1 ROI, followed by the CBF measurements averaged over the 10 subjects in all 3 ROIs—
V1, t-map, and GM ROIs. The PET ΔCBF measurements have a high standard deviation, largely attributable to the abnormally high CBF
measured in subject 8.
Subject Baseline 25% CHB 50% CHB 75% CHB 100% CHB 5% HC
mean CBF in V1 ROI for all 10 subjects (mL/100g tissue/min)
1 47.7 62.5 50.5 49.0 61.3 46.8
2 34.6 54.4 53.4 43.1 52.4 38.1
3 32.6 58.3 42.6 48.6 55.9 39.8
4 42.4 50.4 55.3 45.1 52.0 60.2
5 36.8 51.6 63.0 39.6 43.4 38.4
6 39.5 46.4 74.7 59.6 62.6 50.7
7 62.5 72.5 62.9 64.3 68.6 65.0
8 114.3 139.5 137.8 164.3 148.7 115.9
9 66.1 80.2 53.6 66.65 76.4 66.6
10 50.0 36.6 45.4 37.1 31.8 35.1
Average mean ±std CBF in VI ROI
52.6 ±24.46 5 .2 ±28.96 3 .9 ±27.66 1 .7 ±37.46 5 .3 ±31.95 5 .6 ±24.1
Average mean ± std CBF in t-map ROI
53.6 ±24.57 0 .6 ±27.97 1 .3 ±27.06 8 .9 ±37.67 3 .8 ±30.26 0 .0 ±23.2
Average mean ± std CBF in GM ROI
47.0 ±22.35 2 .8 ±23.25 1 .7 ±20.45 0 .3 ±26.85 2 .8 ±23.94 9 .8 ±21.0
Table 2:FAIRandPETCBFpercentchangesaveragedoverallsubjects(mean ±std),forallconditions(baseline,4levelsofvisualcheckboard
(CHB) stimulation, and hypercapnia (HC)), in the V1, t-map, and GM ROIs. For PET, the baseline percent change was ﬁxed at 0%, since
only one baseline volume was acquired.
Baseline 25% CHB 50% CHB 75% CHB 100% CHB 5% HC
ΔCBF (%)
ROI: retinotopically deﬁned VI (mean ± std)
FAIR 0.6 ±2.61 1 .3 ±5.71 5 .0 ±8.11 7 .5 ±9.42 2 .5 ±11.28 .3 ±6.2
PET 0.0 ±0.02 7 .6 ±27.92 7 .5 ±35.31 6 .3 ±25.02 6 .9 ±30.08 .1 ±19.6
ROI: PET and FAIR t-map overlap (mean ± std)
FAIR 1.1 ±2.71 4 .0 ±8.72 0 .1 ±8.32 3 .5 ±9.12 9 .1 ±8.81 0 .5 ±7.1
PET 0.0 ±0.03 5 .2 ±18.23 8 .4 ±25.52 7 .7 ±22.14 1 .6 ±18.31 5 .7 ±18.0
ROI: occipital lobe grey matter (mean ± std)
FAIR 0.9 ±3.06 .1 ±4.48 .6 ±4.09 .5 ±4.91 2 .8 ±5.17 .9 ±6.2
PET 0.0 ±0.01 5 .0 ±17.81 5 .7 ±28.27 .3 ±18.31 6 .0 ±23.29 .7 ±23.0
PET and FAIR ASL, under conditions extensively used
in numerous brain ﬂow-metabolism studies [3, 25, 26,
41]. The FAIR and PET data were ﬁt to a straight line
taking into account the variations in both modalities. The
resulting slopes were not signiﬁcantly diﬀerent from unity,
though large standard deviations were associated with the
ﬁt. Furthermore, our results showed a consistent monotonic
increase in the CBF percent change (ΔCBF) with stimulus
intensity in the FAIR CBF data which could not be observed
consistently with PET due to its low SNR. On average, FAIR
ΔCBF values were slightly lower than those measured with
PET under the same conditions. Also, a lower SNR was
observed in the FAIR group-average time course, likely due
to intersubject variability and group outliers. Despite these
diﬀerences, the regional ΔCBF values measured with FAIR
were highly correlated with PET measurements.
When comparing PET and fMRI data, a key step was
the transformation of both datasets into the same frame
of reference and to have the same spatial resolution, since
the numerous registration steps could potentially introduce
errors. First of all, PET data had to be aligned between runs
and also to the surface-coil fMRI data, which was in turn
manually registered to the head-coil MR anatomical images
through a process susceptible to intersubject variations.
Subsequently, PET and MR scans were transformed into
Talairach space along with the chosen ROI masks, allowing
for additional image degradation. Moreover, since the fMRI
data consisted of a single slice, no blurring could be per-
formed in the slice direction, and hence the slice resolution
of the FAIR images did not match that of the PET volume
data. In some cases where the fMRI slice may have been
positioned above the activated area, PET data would reﬂectJean J. Chen et al. 9
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Figure 5: FMRI (top) and PET (bottom) CBF percent changes during visual stimulation in the V1, t-map, and GM ROIs. Error bars
represent the standard deviation in the data. Experimental conditions 1 to 5: baseline, 25%, 50%, 75%, and 100% intensity checkerboard
visual stimulation. The FAIR CBF maps have considerably higher SNRs than PET maps, and there was a consistent monotonic increase in
the CBF percent change (ΔCBF) with stimulus intensity in the FAIR data which could not be discerned distinctively in PET given the limited
SNR.
activation while the FAIR data may not, resulting in FAIR
ΔCBF values being lower than those of PET. This may be
one of the sources of the systematic ΔCBF underestimation
using this single-slice FAIR implementation. Furthermore,
since the scan sessions were usually on diﬀerent days,
measurements are prone to various intrasubject variations.
In fact, intrasubject variability as high as 16% has been
reported in the literature for trained subjects [12, 14], and
simple factors such as caﬀeine intake can alter the CBF
response. Othersourcesoferrorsinclude subjectmotion and
respiration. PET data were acquired with lower temporal
resolution and over longer scan periods, thus the eﬀects
of motion would be reduced through data averaging. In
addition, as all PET scans were aligned to the ﬁrst run,
the eﬀect of potential movement between runs was greatly
reduced. Although this process does not account for motion
within runs, the need for in-plane motion correction was
reduced due to the use of image blurring. On the other
hand, each fMRI image was acquired in <100 milliseconds,
and motion could have potentially shifted the location of
the activated region out of the ROI mask, resulting in an
underestimation of the activation as well as diminished
SNR. Complete 3D retrospective motion correction was not
possible for the MR data, since the surrounding regions
were not scanned, but visual examination suggested minimal
displacement between runs or between frames in one run.
Nonetheless, for both PET and MR, intersession positioning
diﬀerences could result in a slight data misalignment and
therefore comparison of slightly shifted brain regions.
An additional source of potential error could originate
from the experimental setup. Although the PET experiments
were designed to reproduce the conditions found in the
MR environment as closely as possible, some elements in
the experimental setup were diﬃcult to reproduce. These
includefactorssuchasheadandmirrororientations,sensory
stimulation induced by MR scanner noise and vibration,
the presence of arterial and venous lines during the PET
experiment,andthedurationofthestudy.Changesinmirror
orientation might occur between subjects and scans. While
this should not have a large impact on the activation if the
subject maintains ﬁxation on the centre, the quality of the
subjects’ attention could be inﬂuenced by the degree of ease10 International Journal of Biomedical Imaging
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Figure 6: Correlation plots of group-average fMRI CBF percent changes with respect to PET CBF changes in the V1, t-map, and GM ROIs.
The dots represent results from baseline and 4 levels of visual stimulation, and the triangles represent the results for the 5% hypercapnia
condition. The equations resulted from the linear ﬁtting of the data, represented by the dotted lines. The hypercapnic ΔCBF measured using
PET and MR are similar. In all 3 cases, the χ2 values have probabilities well within the range of acceptance, and t-test results indicate the
slope of the linear ﬁt is not signiﬁcantly diﬀerent from unity.
with which the stimulus was viewed. Sensory stimulation
from the high background noise and vibration in the MR
scanner, absent in the PET environment, could have added
anadditionalvariability.Thisfactorwas,however,previously
reported to have little impact on the analysis [3]. On the
other hand, in the PET experiments, the stress associated
with having an arterial line and multiple injections could
also have aﬀected the subject’s response. Moreover, the
scan durations for PET and fMRI were diﬀerent; subject
motion generally increases during longer scans. In the fMRI
experiments, nearly 36 minutes of continuous stimulation
was used with no breaks between runs, whereas in PET, the
scan sessions were shorter (4 minutes), and the subjects were
given breaks, relieving strain on subject attention.
Aswementioned,thedependenceofFAIRCBFestimates
on transit delay as well as label width has been previously
discussed [3, 19]. The transit delay is inﬂuenced by the
label gap size, and an underestimation of the delay leads to
CBF underestimation. The quantiﬁcation and correction of
the underestimation requires ASL acquisitions at a range of
diﬀerent inversion times for each ﬂow condition. However,
such measurements could not be included in this study
giventhenumberofgradedﬂowincreasesbeinginvestigated.
Instead, in the FAIR implementation used in this study, we
made an eﬀort to minimize the inﬂuence of transit delays by
using a substantially smaller gap size (3mm) than typically
reported in the literature [3, 20]. In addition, we used body
coil transmission to achieve a very large label width, thereby
minimizing CBF estimation errors due to labeling slab size.
Finally, it should be noted that while the single-slice
FAIR sequence we used did not allow the measurement of
absolute CBF, the literature has recently described various
quantitative and multislice ASL sequences such as Q2TIPS
[5] and QUIPSS II with BASSI pulse tagging [21, 42], which
would better suit future fMRI studies. Multislice perfusion
sequences provide a deﬁnite advantage when studying large
ROIs, reducing the dependence on slice placement, facili-
tating visualization of global CBF changes, and beneﬁting
the clinical utility of ASL perfusion imaging. In addition,
multichannel acquisitions and higher ﬁeld strengths can
provide higher global SNR while abolishing the need for
surface-coil functional scans. This would reduce the number
of steps needed for registration of fMRI and PET data by
eliminating the subject-dependent manual registration step
between head and surface coil anatomical scans. Improved
data SNR and reduced postprocessing variability would per-
mit further exploration of ΔCBF variation with stimulation
intensity.
In recently published studies involving CBF measure-
ments by our group [22, 23], the QUIPSS II technique was
employed [21, 42]. However, as stated earlier, the current
study was motivated by the need to assess the accuracy and
validity of the FAIR method with its known technical limita-
tions, particularly given the importance attached to results
published in recent years based on FAIR measurements
[3, 18, 24, 25, 27]. In addition, we wanted to address the
intense interest in a comprehensive evaluation of the relative
quality of perfusion imaging using MRI and PET, the latterJean J. Chen et al. 11
being the de facto golden standard technique for perfusion
imaging. The chief ﬁnding of the present study is that there
was no signiﬁcant diﬀerence between measurements of CBF
change using PET and FAIR under matched levels of graded
visual stimulation and hypercapnia. These ﬁndings directly
support the argument that FAIR, while leaving room for
improvement, provides a valid measure of CBF changes
under our experimental conditions, characterized by an
accuracy well within the range measured using H2
15OP E T .
The other important observation is that CBF measurements
made using PET have a much lower SNR than those
made using ASL-fMRI, stresses the immense importance in
validating the latter for a wide array of applications.
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